Tech Company Financing Transactions
Fibrocor Therapeutics Funding Round
Fibrocor Therapeutics closed a $2.1 million venture capital round on 1/18/2017. Investors included Mars and private investors.
Transaction Overview
Company Name
Announced On
1/18/2017
Transaction Type
Venture Equity
Amount
$2,100,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Toronto ON, M4B 1B6
Canada
Toronto ON, M4B 1B6
Canada
Phone
Undisclosed
Email Address
Not Recorded
Overview
Fibrocor Therapeutics is focused on developing disease modifying therapeutics in fibrosis. The company has already identified a lead program and will partner with Evotec to develop novel molecules.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Co-Founder
Richard Gilbert
Co-Founder
Jeff Wrana
Co-Founder
Darren Yuen
Browse more venture capital transactions:
Prev: 1/18/2017: Tokyo Smoke venture capital transaction
Next: 1/18/2017: Hypori venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here come from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs